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However, the prognosis may vary greatly with patient char-
acteristics and vascular disease severity. In a review of 10
studies reporting outcomes of femoropopliteal bypass graft-
ing, Hunink et al3 found a 3.6% overall perioperative mor-
tality rate (range, 0.6%-9.7%), which was in turn composed
of a 0.8% rate for patients at low risk and a 4.7% rate for
patients at high risk for mortality. Long-term primary and
assisted patency results are known to vary significantly by
factors such as whether patients have disabling intermittent
claudication or critical leg ischemia (rest pain, gangrene, skin
ulcers), by type of graft material (artificial vs autologous vein
grafts), and by site of distal anastomosis.4,5 Hunink et al2
found adjusted 5-year patency rates that ranged from more
than 80% for saphenous vein grafts for claudication to only
33% for polytetrafluoroethylene grafting for below-knee crit-
ical ischemia. Given this wide range of results, standardized
preoperative risk assessment is fundamental for evaluating
outcomes of lower-extremity bypass grafting surgery.3,6
Cardiac event and mortality rates also are high for
patients with late-stage peripheral vascular disease, with a
The literature on vascular surgery provides strong evi-
dence for highly successful perioperative and long-term arte-
rial patency results for popliteal and infrapopliteal bypass
grafting surgery carried to increasingly distal levels.1,2
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Purpose: A noncardiac surgery risk model was used as a means of analyzing variations in postoperative mortality and
amputation-free survival for older veterans undergoing femorodistal bypass grafting surgery.
Methods: A prospective cohort study was undertaken in 105 Veterans Affairs (VA) hospitals at the time of index oper-
ation from 1991 to 1995. Each patient was linked to subsequent hospitalizations, major amputation surgery, and sur-
vival through 1999. Logistic regression and proportional hazards models were used as a means of developing risk
indices on the basis of risk factors from the VA National Surgical Quality Improvement Program. A total of 4288 male
veterans 40 years or older underwent artificial, vein, or in situ bypass grafting surgery at the femoral to tibial level.
The main outcome measures were 30-day postoperative mortality and amputation-free survival.
Results: Approximately half of all patients had undergone an earlier revascularization or amputation at any level for vas-
cular disease. The 30-day postoperative mortality rate was 2.1% and varied greatly between mortality risk index quar-
tiles (0.6%-5.2%). In a median 44.3 months of follow-up, surviving patients had 17,694 subsequent VA
hospitalizations, 1147 patients (26.7%) underwent subsequent major amputation, and 1913 patients (44.6%) died. The
overall survival probability was 88% at 1 year and 63% at 5 years; 1- and 5-year (any sided) limb salvage rates were 87%
and 74%, respectively, for patients who underwent a femoropopliteal bypass grafting procedure, compared with 77%
and 63%, respectively, for patients who underwent a tibial bypass grafting procedure. When amputation and death were
combined as end points, amputation-free survival probability rates at 1, 3, and 7.5 years were 74%, 56%, and 29%,
respectively. Patients with the best 20% survival risk scores had observed mean survival probability rates 30% higher
than patients in the poorest 20% of survival risk.
Conclusion: Risk indices derived from the preoperative workup may be of use to clinicians in assessing and communi-
cating risk and prognosis. Risk-adjustment of outcomes is critical for evaluating future disease management initiatives
for patients with advanced peripheral arterial disease. (J Vasc Surg 2001;34:283-90.)
5-year survival of only 60% to 70% reported in most
series.7,8 Life-table patency in the vascular surgery litera-
ture is usually defined in a way that deaths are not consid-
ered “failures,” but are right censored (ie, based only on
limbs still “at risk”). Although this traditional approach to
reporting patency rightly gives “credit” for patients who
die with limbs intact, it may provide insufficient evidence
for addressing prognostic concerns about long-term
“cumulative palliation”9 of leg symptoms. Amputation-
free survival, in which either death or major amputation is
considered equally as end points, may be significantly
poorer than traditionally reported life-table patency rates.
However, the reality of limited life expectancy already
often complicates clinical decision making for the oldest
and sickest patients. These patients may have a poor long-
term prognosis, but require lower-extremity revasculariza-
tion procedures to achieve a level of exercise capacity
consistent with maintaining general cardiovascular health
and functional status.10
For this study, we used preoperative history and labo-
ratory findings from the Department of Veterans Affairs
(VA) National Surgical Quality Improvement Program
(NSQIP) as a means of developing multivariable risk mod-
els for both postoperative and long-term survival after
femorodistal bypass grafting surgery. The outcomes
described may be of use as a means of communicating
prognosis with patients and their families. Although study
results are specific to older male veterans, risk factor mod-
els, like those described in this study, will be the founda-
tion for performance assessment by medical centers,
delivery systems, and disease management programs seek-
ing to improve care for this high-risk patient population. 
METHODS
The NSQIP study sample. The VA NSQIP, which
currently includes records for 600,000 noncardiac surgical
operations, was designed as a means of profiling hospital sur-
gical performance across multiple surgical specialties.11-14
From 1991 to 1993, data were collected at 44 higher vol-
ume VA medical centers, with a large additional group of
VA hospitals included from 1993 to 1995. Data were col-
lected by trained surgical nurse reviewers at each partici-
pating VA hospital and include physician-completed
assessments and verification of 30-day postoperative vital
status. NSQIP data include baseline age, race, preopera-
tive vascular disease status, history of amputation or revas-
cularization with side unspecified, rest pain or gangrene,
comorbid conditions (on the basis of 36 NSQIP medical
history items, including diabetes mellitus status, pul-
monary, hepatobiliary, cardiac, renal, central nervous sys-
tem, or nutritional/immune conditions), behavioral
health (smoking, alcohol, and drug use), functional status
(3 categories plus dyspnea at rest or on exertion), emer-
gency operation, American Society of Anesthesiologists
(ASA) class, and do-not-resuscitate status. NSQIP preop-
erative laboratory results were dichotomized to reflect
when a test was ordered and provided an abnormal result;
missing laboratory values, which ranged as high as 25% to
30% of all patients for some tests, were grouped with nor-
mal results. The study was approved by the NSQIP
Executive Committee and the Northwestern University
Institutional Review Board.
Investigators obtained all NSQIP records with princi-
pal or secondary Current Procedural Terminology
(CPT)–4 procedure codes for artificial, vein graft, and in
situ operations at the femoral, popliteal, or tibial levels that
occurred between October 1991 and September 1995.
Operation type (vein graft vs artificial or in situ graft) and
level (femoropopliteal vs tibial) were analyzed separately.
Patients younger than 40 years were excluded from this
analysis to better ensure that results reflected operations
primarily performed for complications of peripheral vascu-
lar disease and diabetes mellitus. A small number of female
patients were also excluded from the analysis because of
insufficient power to reliably detect sex differences. The
chronologically first, “index,” NSQIP admission was
retained for analysis when duplicate NSQIP lower-extrem-
ity bypass grafting surgery admissions of the same patient
occurred between 1991 and 1995. All analyses were thus
performed at the individual patient level after each index
NSQIP surgical admission, going forward in time.
Analysis of 30-day postoperative mortality.
Forward stepwise logistic regression was used as a means
of estimating the effects of NSQIP preoperative risk vari-
ables on the 30-day postoperative mortality rate. With
methods used by the original NSQIP,11 the univariate
association between each candidate predictor variable and
postoperative mortality was examined with χ2 tests for cat-
egorical variables and t tests for continuous variables.
Candidate variables significantly associated with 30-day
mortality at the level of a P value less than .05 were then
entered into the stepwise multivariable model. Final
model results were found to differ little from sequential
50% random validation models. Model discrimination was
measured with the use of the area under the “receiver
operating characteristic” (ROC) curve, with values of 0.5
indicating no discrimination between observed and pre-
dicted outcomes and 1.0 indicating perfect concordance
of predicted and observed outcomes. Model calibration
was measured with the Hosmer-Lemeshow (HL) χ2 test.
Logistic regression model estimates were then used as a
means of computing the 0 to 1 predicted probability of
death for each study patient. Patients were grouped into
four postoperative mortality risk levels on the basis of
stratifying predicted risk into approximate sample quar-
tiles. The resulting four levels of predicted mortality risk
were compared with actual 30-day mortality rates by
means of the χ2 test.
Survival and readmission analyses. The Department
of VA Beneficiary Identification and Retrieval Locator
System Death File and Patient Treatment Admission and
Procedure File records were matched for each patient
through March 1999. Intervals were then computed
between the NSQIP index operation date and date of
death, date of admission for first major above- or below-
knee amputation, or date of last follow-up visit in 1999.
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Kaplan-Meier analyses with log-rank tests were per-
formed as a means of determining the significance of
NSQIP candidate risk factors in predicting time to death
or major amputation. For these analyses, patient age at the
time of operation was divided into three categories, 40 to
64 years, 65 to 74 years, and 75 years and older. Risk fac-
tors with significant log-rank tests and proportional haz-
ards were then included in a forward stepwise Cox
proportional hazards model predicting survival. With the
Charlson15 and related “additive” severity of illness meth-
ods,16,17 NSQIP risk factors with statistically significant
relative risk estimates in the multivariable model were
counted to compute a five-level late survival risk index
scale. Significant relative risks between 1.0 and 2.0 were
assigned a weight of one, and relative risks between 2.0
and 3.0 were assigned a weight of two. Survival risk index
scores were computed for each patient, and the sample
was grouped into approximate quintiles. Survival proba-
bilities between resulting survival risk index levels were
compared by means of the log-rank test.
RESULTS
Sample characteristics and postoperative mortality.
Table I presents selected descriptive statistics from NSQIP
index operations for the 4288 patient sample by type of
operation. These NSQIP-reviewed index admissions
accounted for approximately 25% of all International
Classification of Diseases, Ninth Revision–coded lower-
extremity bypass grafting operations performed in the
same period in the Department of VA system as a whole.
Of the 105 VA hospitals in the NSQIP sample, only eight
had more than 100 patients, with the largest having 204
patients. The most frequent operations were femoro-
popliteal vein and artificial graft procedures, with a large
number of femoral-tibial vein grafts. More than 80% of
patients (mean age, 65.5 years) were judged to have inde-
pendent (as opposed to partially or totally dependent)
functional status preoperatively, approximately 5% were
coded as emergency operations, and approximately 40% of
sample patients had diabetes mellitus. The overall 30-day
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postoperative mortality rate was 2.1%, with the highest
mortality rate for femoral-tibial vein graft operations
(3.3%). As compared with patients who had a principal
procedure code for femoropopliteal bypass grafting, the
1784 sample patients (41.6%) undergoing tibial bypass
grafting procedures had a higher rate of rest pain or gan-
grene (68.7% vs 58.8%, P < .001) and a nonsignificantly
higher 30-day mortality rate (2.5% vs 1.8%, P = .1).
Table II presents risk factors that differed significantly
between patients who survived and patients who were
dead at 30 days. Only risk factors with significant multi-
variable odds ratios are shown for the stepwise logistic
regression results. Despite there being 20 significant vari-
ables at the univariate level, only nine variables were sig-
nificant in the stepwise regression model. Patients who
died were older, more likely to be coded with a vein graft
CPT-4 code, more than four times more likely to have had
a recent myocardial infarction, more than twice as likely to
have had heart failure, and more than five times as likely
to have been on dialysis at the time of operation. Patients
who underwent emergency operations had significantly
higher mortality rates. Abnormal preoperative laboratory
values predicting death included creatinine and serum glu-
tamate oxaloacetate transaminase levels. The model had
moderate predictive performance, with area under the
ROC curve of 0.74, which is equivalent to most validated
cardiac surgery models,18 and moderate calibration (HL
χ2 = 8.7, df = 8, P = .37).
The logistic regression predicted risk of 30-day mortal-
ity was computed for each patient and grouped into four
levels (approximate quartiles) of mean expected mortality
risk. These four groups were then compared by their
observed mean 30-day mortality rate. Patients in the lowest
risk quartile (n = 976) had a 0.6% mean mortality rate, fol-
lowed by the second quartile (n = 865) with 0.8%, the third
quartile (n = 1413) with 1.5%, and the highest risk quartile
(n = 1034) with a 5.2% mean mortality rate (P < .0001).
Readmissions and amputation-free survival. A total
of 99.7% of NSQIP index operations were successfully
matched to patient treatment file (PTF) discharge records
Table I. Sample lower-extremity bypass grafting operations by CPT-4 principle procedure code VA NSQIP, 1991 to 1995
History of
Principle No. of Mean Emergency Diabetes Independent revascularization African Died in
CPT-4 code patients age (y) operations mellitus functional status or amputation American race < 30 d
Fempop (vein) 35556 1147 64.9 6.1% 32.4% 83.7% 48.7% 16.2% 2.4%
Femtib (vein) 35566 838 66.5 5.0% 46.7% 77.6% 52.4% 21.4% 3.3%
Poptib (vein) 35571 199 66.0 11.1% 57.8% 75.4% 47.6% 25.1% 1.5%
Vein graft (all) 2184 65.6 6.1% 40.1% 80.8% 50.1% 19.0% 2.6%
Fempop (in situ) 35583 241 65.2 4.1% 35.2% 88.8% 44.8% 13.3% 0.8%
Femtib (in situ) 35585 469 67.3 4.1% 47.9% 74.4% 39.2% 20.6% 2.6%
Poptib (in situ) 35587 51 67.2 3.9% 68.6% 82.4% 43.1% 23.5% 0.0%
Fempop artificial 35656 1116 64.6 5.2% 34.0% 83.4% 45.3% 18.1% 1.4%
Femtib artificial 35666 186 65.9 8.1% 45.7% 79.0% 57.5% 21.0% 1.1%
Poptib artificial 35671 41 65.8 9.5% 61.9% 69.0% 47.6% 14.3% 0.0%
Total sample 4288 65.5 5.6% 39.9% 81.1% 47.6% 18.7% 2.1%
Fempop, Femoropopliteal; Femtib, femoral-tibial; Poptib, popliteal-tibial.
for the same admission. When NSQIP patients were
matched to PTF data for their index NSQIP admissions, it
was found that 3.5% had died before hospital discharge (as
opposed to a 2.1% 30-day postoperative mortality rate) in
a mean 35-day average length of stay. PTF discharge data
for NSQIP index femorodistal bypass grafting admissions
also revealed a 6.1% overall major amputation rate. This
included some multiple amputations, as revealed by means
of a 4.0% rate of below-knee amputation, a 2.7% rate of
above-knee amputation, and a 4.8% rate of through-foot
amputation. When deaths, major amputation, and
through-foot amputation are combined, 12.5% of NSQIP
patients who underwent bypass grafting procedures either
had died or lost a limb or foot before discharge from the
hospital after their index bypass grafting operation.
There were 17,694 subsequent VA readmissions for
these patients through March 1999; 3642 patients
(84.9%) were readmitted at least once, 2490 patients were
readmitted 3 times, 1559 patients were readmitted 5
times, and 401 patients were readmitted 10 times (the
maximum was 35 readmissions). During the entire follow-
up period, 1913 patients (44.6%) died and 1147 patients
(26.7%) underwent below-knee or above-knee amputa-
tions, including 535 patients who underwent amputation
and also died during the study period. When pooling
major amputation and mortality outcomes, 2515 patients
(58.6%) either had died or undergone a major amputation
by the end of the study period.
Among subsequent operations were 1097 additional
lower-extremity bypass grafting procedures, 115 aortoili-
acfemoral bypass grafting procedures, 651 below-knee
amputations, 585 above-knee amputations, and 197
through-foot amputations. An analysis of readmissions by
means of diagnosis-related group indicated the most com-
mon causes of subsequent admission were peripheral vas-
cular disorders and atherosclerosis (1418); skin ulcers,
cellulitis, wound debridement, and skin procedures
(1023); rehabilitation (459); diabetes mellitus and meta-
bolic disorders (462); infections and septicemia (703);
heart failure (826); angina, chest pain, cardiac arrhythmia,
or other circulatory disorders (1156); acute myocardial
infarction (239); coronary bypass grafting surgery or
angioplasty (209); cerebrovascular disorder or transient
ischemic attack (437); extracranial vascular procedures
(203); renal failure or renal procedures (234); chronic
obstructive pulmonary disease, pneumonia, or respiratory
infection (661); and gastrointestinal hemorrhage, obstruc-
tion, or gastroenteritis (540).
Fig 1 presents separate Kaplan-Meier survival prob-
abilities for limb salvage (by bypass grafting level), with
overall survival probabilities for all study patients super-
imposed. Patients who underwent tibial bypass grafting
procedures had limb-salvage rates that were approxi-
mately 10% lower at each interval than patients who
underwent femoropopliteal bypass grafting procedures
(87%-77% at 1 year, 79%-69% at 3 years, 74%-63% at 
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Table II. Stepwise logistic regression results for preoperative risk factors associated with 30-day postoperative mortality
among 4288 patients undergoing femorodistal bypass grafting
Survivors N (%) Decedents N (%) Multivariate
or mean or mean Univariate odds ratio Multivariate
(SD) N = 4199 (SD) N = 89 P value (95% CI) P value
Age (y) 65.4 (8.5) 69.6 (8.1) < .001 1.1 (1.0-1.08) < .001
Current smoker 2224 (53.0%) 35 (39.3%) .01
Vein graft* 2184 (50.9%) 57 (64.1%) .01 1.6 (1.1-2.6) .03
Dyspnea at rest 47 (1.1%) 3 (3.4%) .05
Functional health status of 778 (18.5%) 34 (38.2%) < .001 1.6 (1.01-2.60) .04
partial/total dependent
Rest pain/gangrene 2631 (62.7%) 68 (76.4%) .008
Ventilator dependent 3 (0.1%) 1 (1.1%) .001
Myocardial infarction in the 66 (1.6%) 8 (9.0%) < .001 4.8 (2.1-1.3) < .001
last 6 months
Hypertension requiring medications 2456 (58.5%) 65 (73.0%) .006
Congestive heart failure within 221 (5.3%) 17 (19.1%) < .001 2.5 (1.4-4.5) .001
previous month
Currently undergoing dialysis 87 (5.3%) 13 (19.1%) < .001 5.7 (2.8-11.8) < .001
Acute renal failure 21 (10.5%) 3 (3.4%) < .001
Impaired sensorium 114 (2.7%) 7 (7.9%) .004
Albumin level > 3.5 g/dL 697 (16.6%) 29 (32.6%) < .001
WBC count > 11 × 103/µL 681 (16.2%) 24 (27.0%) .007
Creatinine level > 1.2 mg/dL 1504 (35.8%) 54 (60.6%) < .001 1.8 (1.1-2.9) .009
SGOT level > 40 IU/L 303 (7.2%) 14 (15.7%) .002 2.1 (1.1-4.0) .02
BUN level > 40 IU/L 182 (4.3%) 12 (13.5%) < .001
Emergency operation 229 (5.5%) 12 (13.5%) .001 2.5 (1.3-4.7) .006
ASA class 4 or 5 4183 (11.5%) 23 (25.8%) < .001
*Vein graft CPT-4 code, as compared with artificial and in situ graft codes.
BUN, blood urea nitrogen; SGOT, serum glutamate oxaloacetate transaminase; WBC, White blood cell.
5 years, and 66%-55% at 7.5 years). Survival probabilities
at each of these intervals were 88%, 71%, 57%, and 43%,
respectively. When either death or major amputation
were combined as a single end point, amputation-free
survival probabilities for all sample patients were 74% at
1 year, 56% at 3 years, 43% at 5 years, and 29% at 7.5
years. Fig 2 presents the Kaplan-Meier amputation-free
survival probabilities for patients with and without
NSQIP chart review documentation of earlier lower-
extremity revascularization or amputation. Comparisons
in both figures were significant (P < .0001), with SEs
less than 0.02 at 7.5 years.
Table III presents the Cox proportional hazards
model of risk factors predictive of time to either major
amputation or death. Eighteen NSQIP preoperative risk
factors were significant. The largest relative risks were for
dialysis (the only relative risk > 2.0), ASA class 4 or 5 (as
compared with class 1 or 2), abnormal albumin levels, dis-
seminated cancer, and age older than 74 years. Patients
with diabetes mellitus were approximately 1.5 times more
likely to die or undergo subsequent amputation.
Table IV presents a resulting five-level survival risk
index derived from counting each patient’s significant risk
factors from Table III (with a weight of 2.0 for patients
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undergoing dialysis). Differences in median follow-up
time in months and 1- and 5-year Kaplan-Meier amputa-
tion-free survival probabilities are presented for patients
grouped by the five-level survival index. There is a striking
spread of survival probabilities between the highest and
lowest levels of risk of 85% to 51% at 1 year and 60% to
19% at 5 years (P < .0001).
CONCLUSIONS
Knowledge of risks related to a variety of long- and
short-term outcomes is essential to good communication
with patients and their families about undergoing this
often urgent and high-risk operation. Clearly, operative
risk and long-term prognosis play an important role in
deciding which patients are even referred to vascular
surgery. Risk indices, such as those presented here, are
only valid in comparison with the risks of amputation
surgery, expected survival after amputation surgery,19,20
and functional and pain outcomes. Computation of com-
peting risks for a specified outcome across a wide range of
potential risk factors is becoming easier with pocket calcu-
lators and computers. The results presented here indicate
the potential of such methods to clearly stratify outcomes
across a diverse group of patients.
Fig 1. Kaplan-Meier survival probabilities for limb salvage (by lower-extremity bypass graft level) and death for 4288 patients under-
going operations at 105 VA hospitals from 1991 to 1995. Above- or below-knee amputation (any side) survival probabilities are pre-
sented with deaths censored for 1784 patients (41.6%) with VA NSQIP CPT-4 procedure codes for tibial bypass grafting, as compared
with 2504 patients (58.4%) with femoropopliteal codes (log rank test, P < .0001). Curve for overall Kaplan-Meier survival probability
for all 4288 patients is superimposed. 
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Fig 2. Amputation-free survival after femorodistal bypass grafting surgery for 4288 patients undergoing operations at 105 VA hospitals
from 1991 to 1995. Kaplan-Meier survival probabilities for time to either above- or below-knee amputation (any side) or death for
patients with or without VA NSQIP documentation of history of revascularization or major amputation (any level) for peripheral vas-
cular disease (log rank test, P < .0001).
Table III. Cox proportional hazards model results for risk factors for amputation-free survival after surgery for 4288
patients undergoing femorodistal bypass grafting
Relative risk (95% CI) Significance
Sodium level > 135 mmol/L 1.2 (1.2-1.4) < .0001
WBC count > 11 × 103 g/µL 1.1 (1.04-1.3) .008
Diabetes mellitus 1.4 (1.3-1.6) < .0001
History of stroke with neurologic deficit 1.1 (1.0-1.2) .02
ASA class 3 1.2 (1.0-1.4) .01
ASA class 4 or 5 1.4 (1.2-1.8) < .0001
Partially dependent functional status 1.3 (1.2-1.5) < .0001
Albumin level < 3.5 g/dL 1.5 (1.4-1.7) < .0001
Aged 65-74 y 1.2 (1.2-1.3) < .0001
Older than 74 y 1.4 (1.2-1.5) < .0001
Currently undergoing dialysis 2.5 (2.0-3.1) < .0001
Disseminated cancer 1.6 (1.0-2.5) .03
Emergency operation 1.2 (1.0-1.5) .01
Congestive heart failure within month 1.3 (1.1-1.5) .002
History of COPD 1.24 (1.1-1.4) < .0001
Earlier LE revascularization or amputation 1.2 (1.1-1.3) < .0001
Tibial bypass graft 1.1 (1.0-1.2) .002
Rest pain/gangrene 1.2 (1.0-1.3) < .0001
COPD, Chronic obstructive pulmonary disease; LE, lower extremity; WBC, white blood cell.
There will be an inevitable growth in the absolute
number and proportion of older Americans with predis-
posing conditions for progressive vascular disease.21 As
many as 5% of older Americans may have symptoms of
intermittent claudication, with incidence rates increasing
with age. A much larger proportion of the older popula-
tion has asymptomatic lower-extremity vascular disease or
atypical leg symptoms.22 Growth in the indications for
invasive vascular disease treatment and the persistence of
high rates of major primary amputation suggest the need
for more vigorous monitoring of risk-adjusted patient
outcomes.
This study of older male veterans is limited in several
ways. The study relies on chart review of a selected,
although large, proportion of patients treated in the
Department of VA system and uses medical record
abstractions that fail to indicate the side of bypass grafting
procedure or amputation or functional status after the
operation. The proportion of VA or private-sector patients
undergoing bypass grafting surgery for disabling intermit-
tent claudication, as opposed to critical leg ischemia (rest
pain, gangrene, skin ulcers), is not known. However, there
is evidence that older patients with vascular disease and
diabetes mellitus treated in VA settings are more function-
ally impaired and have a higher burden of comorbid con-
ditions.23,24 Although the NSQIP sample analyzed here
may reflect some selection bias in VA bypass grafting
surgery admissions never abstracted, these results are likely
to reflect a greater burden of illness and critical leg
ischemia than is normally found among private-sector
patients. Amputation-free survival is inevitably poorer
than traditional, death-censored patency or limb salvage
outcomes. Therefore, most of the patients studied here
may have had no alternative to immediate major amputa-
tion had they not undergone bypass grafting surgery.
It is essential to properly capture the true burden of
illness and sociodemographic factors in risk adjustment if
comparisons are made between outcomes at hospitals and
health systems. Such comparisons will require more uni-
form preoperative data collection, and even then the
Department of VA’s commitment to information systems
and quality management, albeit limited, is rarely available
in nonacademic private settings. As specialty-specific out-
comes information systems and decision aids become
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more fully developed among health care systems, additive
risk indices will be essential in developing benchmarks of
expected mortality, complications, and survival for use in
institutional quality improvement efforts.
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